United States 119th Congress Status: In Committee Bipartisan · 3 D · 1 R cosponsors

HR 6320 — Improving Medicaid Precision and Cancer Test Act of 2025

Last action — Referred to the House Committee on Energy and Commerce.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced November 28, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Prognosis

Advancing 38% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 4 sponsors

    1 primary, 3 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (3 D · 1 R) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

How this bill changes current law

5 changes Share ↗

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill requires Medicaid to cover lung cancer biomarker testing, expanding the list of covered services under the program.

  • 42 U.S.C. 1396a

    (30) → (30), and (32)

    This change adds lung cancer biomarker testing as a required coverage under Medicaid.

  • 42 U.S.C. 1396d

    ; and → ;

    This punctuation change allows the addition of a new service to the list of Medicaid covered items.

  • 42 U.S.C. 1396d

    paragraph (32) → paragraph (33)

    This change adjusts the numbering of the existing covered services to accommodate the new addition.

  • 42 U.S.C. 1396d

    (32) lung cancer biomarker testing; and

    This addition explicitly includes lung cancer biomarker testing as a covered service under Medicaid.

  • 42 U.S.C. 1397f

    , and beginning January 1, 2027, coverage of lung cancer biomarker testing

    This change establishes a timeline for when the coverage for lung cancer biomarker testing will take effect.

Action History

  1. Introduced in House

  2. Introduced in House

  3. Referred to the House Committee on Energy and Commerce.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 3 co-sponsors · 543 not signed on

Sponsors (1)

Co-sponsors (3)

Not signed on (543)

543 members have not signed on to this bill.

Show all 543 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HR 6320?
HR 6320 is sponsored by Gottheimer, Josh (Democratic), Rutherford, John H. (Republican), Swalwell, Eric (Democratic), and Grijalva, Adelita S. (Democratic).
What is the current status of HR 6320?
This bill is in committee in the House. Introduced November 28, 2025. It must pass committee before a floor vote.
Where can I track HR 6320?
Track HR 6320 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 6320

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 6320

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →